/
/
/

Rossari Biotech Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019
₹697 Cr₹685 Cr₹582 Cr₹586 Cr₹544 Cr₹580 Cr₹513 Cr₹498 Cr₹490 Cr₹473 Cr₹464 Cr₹483 Cr₹411 Cr₹406 Cr₹389 Cr₹425 Cr₹435 Cr₹439 Cr₹428 Cr₹385 Cr₹231 Cr₹218 Cr₹210 Cr₹172 Cr₹109 Cr₹160 Cr₹162 Cr₹150 Cr₹128 Cr
₹3 Cr₹19 Cr₹51 L₹2 Cr₹1 Cr₹2 Cr₹55 L₹72 L₹95 L₹39 L₹4 Cr₹1 Cr₹2 Cr₹3 Cr₹1 Cr₹82 L₹74 L₹2 Cr₹5 Cr₹4 Cr₹3 Cr₹3 Cr₹76 L₹4 Cr₹2 Cr₹2 Cr₹6 L₹84 L₹78 L
₹700 Cr₹704 Cr₹582 Cr₹588 Cr₹545 Cr₹581 Cr₹513 Cr₹499 Cr₹491 Cr₹473 Cr₹467 Cr₹485 Cr₹413 Cr₹409 Cr₹390 Cr₹426 Cr₹435 Cr₹441 Cr₹434 Cr₹388 Cr₹234 Cr₹221 Cr₹211 Cr₹176 Cr₹111 Cr₹162 Cr₹162 Cr₹151 Cr₹129 Cr
₹642 Cr₹631 Cr₹532 Cr₹532 Cr₹494 Cr₹528 Cr₹466 Cr₹448 Cr₹440 Cr₹425 Cr₹415 Cr₹435 Cr₹367 Cr₹368 Cr₹351 Cr₹385 Cr₹392 Cr₹403 Cr₹398 Cr₹351 Cr₹200 Cr₹190 Cr₹182 Cr₹147 Cr₹90 Cr₹140 Cr₹137 Cr₹126 Cr₹109 Cr
₹84 Cr₹96 Cr₹69 Cr₹74 Cr₹69 Cr₹71 Cr₹65 Cr₹67 Cr₹66 Cr₹64 Cr₹67 Cr₹65 Cr₹60 Cr₹57 Cr₹55 Cr₹57 Cr₹58 Cr₹54 Cr₹53 Cr₹48 Cr₹40 Cr₹38 Cr₹35 Cr₹34 Cr₹25 Cr₹26 Cr₹30 Cr₹29 Cr₹23 Cr
₹11 Cr₹9 Cr₹8 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹5 Cr₹6 Cr₹4 Cr₹5 Cr₹8 Cr₹5 Cr₹5 Cr₹3 Cr₹2 Cr₹63 L₹80 L₹36 L₹69 L₹1 Cr₹1 Cr₹87 L₹1 Cr₹46 L
₹47 Cr₹64 Cr₹42 Cr₹49 Cr₹46 Cr₹48 Cr₹42 Cr₹48 Cr₹47 Cr₹45 Cr₹48 Cr₹45 Cr₹40 Cr₹37 Cr₹35 Cr₹34 Cr₹38 Cr₹33 Cr₹32 Cr₹36 Cr₹33 Cr₹30 Cr₹28 Cr₹28 Cr₹20 Cr₹20 Cr₹25 Cr₹24 Cr₹19 Cr
₹35 Cr₹45 Cr₹32 Cr₹36 Cr₹33 Cr₹34 Cr₹31 Cr₹35 Cr₹35 Cr₹34 Cr₹34 Cr₹33 Cr₹29 Cr₹29 Cr₹26 Cr₹24 Cr₹28 Cr₹23 Cr₹22 Cr₹26 Cr₹25 Cr₹22 Cr₹22 Cr₹21 Cr₹15 Cr₹15 Cr₹18 Cr₹18 Cr₹14 Cr

Share Price Live Stats

Open (₹)461.00
Volume (₹)83,167.00
High (₹)468.25
Upper Circuit548.40
Low (₹)456.10
Lower Circuit365.60
Prev Close457.00
52W High (₹)690.30
Price461.00
52W Low (₹)375.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)2531.23 Cr
Div. Yield (%)0.11
PE Ratio16.80
Debt to Equity0.31
Price to Book1.58
Book Value239.75
EPS (TTM)27.21
Face Value2.00
ROE (%)11.88

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
NAVINFLUORNSE
GODREJINDNSE
DEEPAKNTRNSE
AETHERNSE
ATULNSE
AARTIINDNSE
ROSSARINSE
LTP
1W Low
1W High
Market cap (₹)
21445+1045 (5.12%)
19810
21695
1,93,746Cr
1629.5+0 (0.00%)
1612.40
1687.70
1,66,118Cr
2547-42.9 (-1.66%)
2532.20
2648
77,219Cr
4565-206.2 (-4.32%)
4461.10
4850
51,537Cr
8553+35.5 (0.42%)
8275.50
8740
44,624Cr
1173+5.5 (0.47%)
1128.50
1215.90
38,937Cr
1715.1-47.8 (-2.71%)
1705.70
1820
23,559Cr
1625-71.8 (-4.23%)
1614.30
1707.80
21,984Cr
6376-83.5 (-1.29%)
6358
6642.50
19,036Cr
493.25-47.1 (-8.72%)
490
540.60
18,200Cr
461-37.1 (-7.45%)
451.40
504.70
2,531Cr

Key Highlights of Rossari Biotech Ltd’s P&L

In 2026-03-31, Rossari Biotech Ltd reported total revenue of ₹2435.6Cr, compared with ₹2095.19Cr in 2025-03-31, reflecting Rossari Biotech Ltd turnover.

Depreciation was ₹79.12Cr and finance costs were ₹28.54Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹202.51Cr in 2026-03-31 as compared to ₹185.19Cr in 2025-03-31.

Net Profit (PAT) was ₹149.21Cr in 2026-03-31 compared with ₹136.38Cr in 2025-03-31.

Earnings per share (EPS) were ₹26.94 in 2026-03-31, compared with ₹24.63 in 2025-03-31.